De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!
Hologic Beheer
Beheer criteriumcontroles 4/4
De CEO Hologic's is Steve MacMillan, benoemd in Dec2013, heeft een ambtstermijn van 10.83 jaar. De totale jaarlijkse vergoeding van { bedraagt $ 15.56M, bestaande uit 7.6% salaris en 92.4% bonussen, inclusief aandelen en opties van het bedrijf. bezit rechtstreeks 0.99% van de aandelen van het bedrijf, ter waarde $ 187.72M. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 3.7 jaar en 7.8 jaar.
Belangrijke informatie
Steve MacMillan
Algemeen directeur
US$15.6m
Totale compensatie
| Percentage CEO-salaris | 7.6% |
| Dienstverband CEO | 10.8yrs |
| Eigendom CEO | 1.0% |
| Management gemiddelde ambtstermijn | 3.7yrs |
| Gemiddelde ambtstermijn bestuur | 7.8yrs |
Recente managementupdates
Recent updates
Hologic (NASDAQ:HOLX) Has More To Do To Multiply In Value Going Forward
Sep 16
Hologic, Inc. (NASDAQ:HOLX) Not Flying Under The Radar
Sep 01Hologic Has A Lot Of Fine Qualities, But A Discount Valuation Isn't Among Them
Aug 27Is There Now An Opportunity In Hologic, Inc. (NASDAQ:HOLX)?
Jul 21These 4 Measures Indicate That Hologic (NASDAQ:HOLX) Is Using Debt Reasonably Well
Jun 20Returns At Hologic (NASDAQ:HOLX) Appear To Be Weighed Down
May 22Hologic: Women's Health Play Looks Healthier Itself
May 13Getting In Cheap On Hologic, Inc. (NASDAQ:HOLX) Might Be Difficult
Apr 19Calculating The Intrinsic Value Of Hologic, Inc. (NASDAQ:HOLX)
Apr 05Hologic (NASDAQ:HOLX) Has A Pretty Healthy Balance Sheet
Mar 20Why Hologic, Inc. (NASDAQ:HOLX) Could Be Worth Watching
Feb 22Hologic: Prospects For Growth As Headwinds Disappear
Feb 11We Think You Can Look Beyond Hologic's (NASDAQ:HOLX) Lackluster Earnings
Feb 09Hologic, Inc. Just Beat EPS By 32%: Here's What Analysts Think Will Happen Next
Feb 06We Like These Underlying Return On Capital Trends At Hologic (NASDAQ:HOLX)
Jan 29The Price Is Right For Hologic, Inc. (NASDAQ:HOLX)
Dec 30Are Investors Undervaluing Hologic, Inc. (NASDAQ:HOLX) By 25%?
Dec 11We Think Hologic (NASDAQ:HOLX) Can Stay On Top Of Its Debt
Nov 08Should You Think About Buying Hologic, Inc. (NASDAQ:HOLX) Now?
Oct 25Slowing Rates Of Return At Hologic (NASDAQ:HOLX) Leave Little Room For Excitement
Sep 28Hologic, Inc.'s (NASDAQ:HOLX) Intrinsic Value Is Potentially 35% Above Its Share Price
Aug 29We Think Hologic (NASDAQ:HOLX) Can Stay On Top Of Its Debt
Jul 31Why Hologic, Inc. (NASDAQ:HOLX) Could Be Worth Watching
Jul 18Return Trends At Hologic (NASDAQ:HOLX) Aren't Appealing
Jun 21Calculating The Fair Value Of Hologic, Inc. (NASDAQ:HOLX)
May 22We Think Hologic (NASDAQ:HOLX) Can Stay On Top Of Its Debt
Apr 25What Does Hologic, Inc.'s (NASDAQ:HOLX) Share Price Indicate?
Apr 10Hologic's (NASDAQ:HOLX) Returns On Capital Are Heading Higher
Mar 13Calculating The Fair Value Of Hologic, Inc. (NASDAQ:HOLX)
Feb 14Hologic (NASDAQ:HOLX) Seems To Use Debt Quite Sensibly
Jan 18Is Now The Time To Look At Buying Hologic, Inc. (NASDAQ:HOLX)?
Jan 03Analyse CEO-vergoeding
| Datum | Totale vergoeding | Salaris | Bedrijfswinsten |
|---|---|---|---|
| Jun 29 2024 | n/a | n/a | US$702m |
| Mar 30 2024 | n/a | n/a | US$467m |
| Dec 30 2023 | n/a | n/a | US$515m |
| Sep 30 2023 | US$16m | US$1m | US$456m |
| Jul 01 2023 | n/a | n/a | US$484m |
| Apr 01 2023 | n/a | n/a | US$753m |
| Dec 31 2022 | n/a | n/a | US$990m |
| Sep 24 2022 | US$14m | US$1m | US$1b |
| Jun 25 2022 | n/a | n/a | US$2b |
| Mar 26 2022 | n/a | n/a | US$2b |
| Dec 25 2021 | n/a | n/a | US$2b |
| Sep 25 2021 | US$15m | US$1m | US$2b |
| Jun 26 2021 | n/a | n/a | US$2b |
| Mar 27 2021 | n/a | n/a | US$2b |
| Dec 26 2020 | n/a | n/a | US$1b |
| Sep 26 2020 | US$14m | US$1m | US$1b |
| Jun 27 2020 | n/a | n/a | US$497m |
| Mar 28 2020 | n/a | n/a | US$453m |
| Dec 28 2019 | n/a | n/a | US$84m |
| Sep 28 2019 | US$12m | US$1m | -US$204m |
| Jun 29 2019 | n/a | n/a | -US$30m |
| Mar 30 2019 | n/a | n/a | -US$11m |
| Dec 29 2018 | n/a | n/a | -US$419m |
| Sep 29 2018 | US$42m | US$1m | -US$111m |
Compensatie versus markt: De totale vergoeding ($USD 15.56M ) Steve } is ongeveer het gemiddelde voor bedrijven van vergelijkbare omvang in de US markt ($USD 13.04M ).
Compensatie versus inkomsten: De vergoeding van Steve is het afgelopen jaar in lijn geweest met de bedrijfsprestaties.
CEO
Steve MacMillan (60 yo)
10.8yrs
Tenure
US$15,555,032
Compensatie
Mr. Stephen P. MacMillan, also known as Steve, serves as an Independent Chairman of the Board at Illumina, Inc. from June 02, 2023. He has been the Chairman of the Board at Hologic Inc. since June 17, 2015...
Leiderschapsteam
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| Chairman | 10.8yrs | US$15.56m | 0.99% $ 184.9m | |
| Chief Financial Officer | 6.2yrs | US$3.93m | 0.036% $ 6.7m | |
| Chief Operating Officer | less than a year | US$2.17m | 0.00018% $ 33.5k | |
| General Counsel | 9.7yrs | US$3.34m | 0.046% $ 8.6m | |
| Group President of International | no data | US$3.52m | 0.031% $ 5.8m | |
| Chief Information Officer | 3.3yrs | geen gegevens | geen gegevens | |
| Vice President of Investor Relations | no data | geen gegevens | geen gegevens | |
| Senior Vice President of Global Human Resources | less than a year | geen gegevens | geen gegevens | |
| VP & Chief of Staff | 10.8yrs | geen gegevens | geen gegevens | |
| Division President of Breast & Skeletal Health Solutions | 4.2yrs | geen gegevens | 0.0071% $ 1.3m | |
| President of Diagnostics Solutions | 1.5yrs | geen gegevens | 0.0027% $ 508.8k | |
| Senior Vice President of Global Supply Chain | less than a year | geen gegevens | geen gegevens |
3.7yrs
Gemiddelde duur
56yo
Gemiddelde leeftijd
Ervaren management: Het managementteam van HOLX wordt beschouwd als ervaren (gemiddelde ambtstermijn 3.7 jaar).
Bestuursleden
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| Chairman | 10.8yrs | US$15.56m | 0.99% $ 184.9m | |
| Independent Director | 11.4yrs | US$339.96k | 0.018% $ 3.4m | |
| Independent Director | 17yrs | US$374.96k | 0.057% $ 10.5m | |
| Independent Director | 1.8yrs | US$338.44k | 0.000070% $ 13.0k | |
| Independent Director | 5.9yrs | US$319.96k | 0.0025% $ 467.8k | |
| Independent Director | 7.4yrs | US$344.96k | 0.0066% $ 1.2m | |
| Independent Director | 12.9yrs | US$319.96k | 0.019% $ 3.5m | |
| Lead Independent Director | 7.8yrs | US$319.96k | 0.0076% $ 1.4m | |
| Independent Director | 1.1yrs | US$128.96k | 0.00032% $ 59.6k |
7.8yrs
Gemiddelde duur
61yo
Gemiddelde leeftijd
Ervaren bestuur: De raad van bestuur van HOLX wordt beschouwd als ervaren (gemiddelde ambtstermijn 7.8 jaar).